Epstein Secrets

rts and venture capitalists including, for example, close cooperative relationships with Khosla Ventures and ARCH Venture Partners. • Support from Bill Gates, who we expect to be a significant investor through associated entities which have already provided funding for the first warehoused investment of B

led investments in various life- science/IT/healthcare companies such as Foundation Medicine and Research Gate, served on the board of directors of Schrodinger, and monitored Nimbus. On the not-for-profit side, Dr. Nikolic co- managed BMGF's $1.5 billion strategic-investment pool, focused on program-related

Y 2012 and projections for FY 2014 and FY 2015). Questions were asked and a full discussion followed. Mr. Friesner summarized his conversation with Bill Gates in December 2013 on a possible future financing by Mr. Gates. Mr. Guidero stated he would consult with Mr. Gates regarding the potential financing.

(by phone) 1. Call to Order. A meeting of the Board of Directors of Schrodinger, Inc. (the "Board"), a Delaware corporation, (the "Company" or "Schrodinger") was held at the above place and time. Mr. Ardai, presiding as Chairman of the meeting, conducted a roll call and confirmed that Mr. Nikolic, Mr.

vioural point of view saving is a deeply ingrained human behaviour that borders on the compulsive. Most people put money away for a rainy day. While Bill Gates and Warren Buffet have shown extraordinary benevolence, they both continue to hoard wealth far beyond their possible needs. Leaving biology aside,

intuitively wrong. In most of the things that humans count, more is better, while with entropy less is normally better. In later sections I follow Schrodinger in using the concept of 'negentropy' (negative-entropy) to get round this problem. The important point of the energy/information debate is that the

invested in or know; Breakthrough Life Sciences Prize recipients; DST technology investment team, and; entities associated with our anchor investor Bill Gates, such as Bill Gates Ventures and the Bill and Melinda Gates Foundation. We are in the process of entering into an agreement with illumine, the leadi

activities. On the for-profit side, Boris led investments in various life science/health care companies such as Foundation Medicine, Research Gate, Schrodinger and Nimbus through Bill Gates Ventures. On the non-for profit side, Boris co-managed BMGF's $1.5 billion strategic investment pool focused on progr